The analysis assesses Pfizer's stock as a hold/accumulate with a score of 0.801. It indicates a horizontal trend with minor fluctuations, projecting a 0.85% change over the next three months, and a potential range between -3.06% and 12.28%. Over 12 months, a -6.9% change is expected, varying from -22.77% to 2.76%. The last trading day showed a 1.48% gain, closing at $24.65, with 2.36% daily fluctuation, but warns of divergence due to falling volume during price gains. Fibonacci analysis is mentioned, the analyst ratings for the PFE rate the stock to buy. The insider power ratio is 97.518. Support is defined at $24.29, while the stock also has potential key levels to watch. A stop loss is recommended at $23.36 (-5.23%).